Oncology & Cancer

Therapy targets leukemia stem cells

New research takes aim at stubborn cancer stem cells that are thought to be responsible for treatment resistance and relapse. The study, published by Cell Press in the February 14 issue of the journal Cancer Cell, provides ...

Diseases, Conditions, Syndromes

Study suggests new way to ensure effectiveness of TB treatment

A UT Southwestern Medical Center study using a sophisticated "glass mouse" research model has found that multidrug-resistant tuberculosis (TB) is more likely caused in patients by speedy drug metabolism rather than inconsistent ...

Diseases, Conditions, Syndromes

New TB treatment limits infection while reducing drug resistance

It's estimated that nearly one-third of the world's population -- more than two billion people -- are infected with Mycobacterium tuberculosis. According to the World Health Organization, 5 to 10 percent of infected people ...

Oncology & Cancer

Basic biology offers clues to better neuroblastoma treatments

By studying tumor biology at the molecular level, researchers are gaining a deeper understanding of drug resistance -- and how to avoid it by designing pediatric cancer treatments tailored to specific mutations in a child's ...

Diseases, Conditions, Syndromes

Hope for powerful new C diff. treatment

MGB Biopharma, a biopharmaceutical company which has licensed technology from the University of Strathclyde in Glasgow, Scotland, is developing a powerful new antibiotic treatment for resistant infections including the deadly ...

Oncology & Cancer

Gene therapy kills breast cancer stem cells, boosts chemotherapy

Gene therapy delivered directly to a particularly stubborn type of breast cancer cell causes the cells to self-destruct, lowers chance of recurrence and helps increase the effectiveness of some types of chemotherapy, researchers ...

page 39 from 40